Three-dimensional mean disease alleviation (3D-MDA): The next step in measuring sleep apnea treatment effectiveness

IF 3.4 2区 医学 Q1 CLINICAL NEUROLOGY Sleep medicine Pub Date : 2025-01-01 Epub Date: 2024-11-16 DOI:10.1016/j.sleep.2024.11.027
Thomas M. Kaffenberger , Ryan J. Soose , Patrick J. Strollo , Olivier M. Vanderveken
{"title":"Three-dimensional mean disease alleviation (3D-MDA): The next step in measuring sleep apnea treatment effectiveness","authors":"Thomas M. Kaffenberger ,&nbsp;Ryan J. Soose ,&nbsp;Patrick J. Strollo ,&nbsp;Olivier M. Vanderveken","doi":"10.1016/j.sleep.2024.11.027","DOIUrl":null,"url":null,"abstract":"<div><div>Mean disease alleviation measures the effectiveness of Obstructive Sleep Apnea (OSA) treatments. It combines a patient's adherence to treatment normalized to their total sleep time and the treatment's efficacy as determined by the change in the apnea-hypopnea index. This metric fails to capture the patient's OSA-related symptoms, which are a key component and, in some cases, the primary component, of determining response to treatment.</div><div>We propose an enhanced metric called three-dimensional mean disease alleviation (3D-MDA), which incorporates the symptom response to better reflect the true treatment impact.</div></div><div><h3>Results</h3><div>The proposed 3D-MDA metric aims to provide a more comprehensive assessment of OSA treatment effectiveness by integrating the subjective impact, therapy adherence, and objective efficacy. Further, 3D-MDA is adaptable over time as the optimal metrics for these categories continue to evolve.</div></div>","PeriodicalId":21874,"journal":{"name":"Sleep medicine","volume":"125 ","pages":"Pages 27-30"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1389945724005306","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Mean disease alleviation measures the effectiveness of Obstructive Sleep Apnea (OSA) treatments. It combines a patient's adherence to treatment normalized to their total sleep time and the treatment's efficacy as determined by the change in the apnea-hypopnea index. This metric fails to capture the patient's OSA-related symptoms, which are a key component and, in some cases, the primary component, of determining response to treatment.
We propose an enhanced metric called three-dimensional mean disease alleviation (3D-MDA), which incorporates the symptom response to better reflect the true treatment impact.

Results

The proposed 3D-MDA metric aims to provide a more comprehensive assessment of OSA treatment effectiveness by integrating the subjective impact, therapy adherence, and objective efficacy. Further, 3D-MDA is adaptable over time as the optimal metrics for these categories continue to evolve.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
三维平均疾病缓解率(3D-MDA):测量睡眠呼吸暂停治疗效果的下一步。
平均疾病缓解率衡量阻塞性睡眠呼吸暂停(OSA)的治疗效果。它将患者的治疗依从性与他们的总睡眠时间和根据呼吸暂停-低通气指数的变化确定的治疗效果相结合。这一指标未能反映患者与 OSA 相关的症状,而这些症状是决定治疗反应的关键因素,在某些情况下甚至是主要因素。我们提出了一种名为三维平均疾病缓解率(3D-MDA)的增强型指标,它结合了症状反应,能更好地反映真实的治疗效果。结果:所提出的三维平均疾病缓解度量标准旨在通过整合主观影响、治疗依从性和客观疗效,对 OSA 治疗效果进行更全面的评估。此外,随着这些类别的最佳衡量标准不断发展,3D-MDA 也可随时间推移而调整。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Sleep medicine
Sleep medicine 医学-临床神经学
CiteScore
8.40
自引率
6.20%
发文量
1060
审稿时长
49 days
期刊介绍: Sleep Medicine aims to be a journal no one involved in clinical sleep medicine can do without. A journal primarily focussing on the human aspects of sleep, integrating the various disciplines that are involved in sleep medicine: neurology, clinical neurophysiology, internal medicine (particularly pulmonology and cardiology), psychology, psychiatry, sleep technology, pediatrics, neurosurgery, otorhinolaryngology, and dentistry. The journal publishes the following types of articles: Reviews (also intended as a way to bridge the gap between basic sleep research and clinical relevance); Original Research Articles; Full-length articles; Brief communications; Controversies; Case reports; Letters to the Editor; Journal search and commentaries; Book reviews; Meeting announcements; Listing of relevant organisations plus web sites.
期刊最新文献
Perceptions of school start times and adolescent sleep by WHO region Who misuses sedatives for sleep? Evidence from a nationally representative US sample Digital insomnia therapeutic as a workplace performance solution for improving productivity Sleep and its associations with other health behaviours and sociodemographic factors in Australian children under 5 years old Factors associated with inadequate sleep among high school students in New Mexico: Data from the New Mexico Youth Risk and Resiliency Survey 2015-2023
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1